Status:
UNKNOWN
Real Life Experience of the Use of Isomers as ALENCAL (Levamlodipine) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients
Lead Sponsor:
Closter Pharma
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This is a Phase 4, observational, open study in patients whom their doctor for clinical practice prescribes levamlodipine. No medication was provided by the sponsor. The planned observation time is 8 ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients whose primary physician based on their clinical condition and locally approved use will be eligible to participate in this study, and have been prescribe with Levamlodipine.
Exclusion
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT01429233
Start Date
August 1 2011
End Date
March 1 2012
Last Update
September 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Country Club Bogota
Bogotá, Colombia